Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis
- 1 September 1999
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 354 (9184), 1053-1060
- https://doi.org/10.1016/s0140-6736(98)11293-x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trialJournal of Hepatology, 2000
- Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applicationsHepatology, 1998
- Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosisGastroenterology, 1997
- Primary Biliary Cirrhosis: Questions and PromisesAnnals of Internal Medicine, 1997
- Short-term treatment of gastric ulcerDigestive Diseases and Sciences, 1996
- Quality, Evolution, and Clinical Implications of Randomized, Controlled Trials on the Treatment of Lung CancerJAMA, 1989
- IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?The Lancet, 1987
- Primary Biliary CirrhosisThe New England Journal of Medicine, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Serum bilirubin: a prognostic factor in primary biliary cirrhosis.Gut, 1979